top of page

Project Twenty21 – Scientific Oversight Board

Drug Science Logo

Project Twenty21 is committed to scientific excellence and the development of independent scientific evidence. It is supported by a scientific oversight board, consisting of the following expertise:

  • Professor David Nutt DM, FRCP, FRCPSYCH, FSB, FMEDSCI. Professor of Neuropsychopharmacology at Imperial College London.

  • Professor Eileen Joyce MA, PhD, MB BChir, MRCP, FRCPsych Professor of Neuropsychiatry at The Institute of Neurology, University College London.

  • Professor Michael Lynskey BSc (Hons), MSc, PhD. Epidemiologist.

  • Professor Val Curran MA (Cantab) PhD D CLin Psy FRSB; Director UCL Clinical Psychopharmacology Unit.

  • Professor Adam Winstock MD MRCPsych MRCP FAChAM. Consultant Psychiatrist and Addiction Medicine Specialist.

  • Dr Alan Fayaz MD(Res) MRCP FRCA FFPMRCA. Consultant in Anaesthesia and Pain Medicine at University College London Hospital NHS Foundation Trust.

  • Dr Elizabeth Iveson MBCHB FRCP (UK). Consultant Stroke, Elderly and Neurorehabilitation Physician.

  • Dr Tim Williams MD PhD MRCPsych. Consultant addiction psychiatrist and clinical director for Avon and Wiltshire Mental Health Trust.

  • Dr Chloe Sakal MBBS BSc MRCPsych – Clinical Director for Project Twenty21

Twenty21 Study Protocol

Keep up with developments in drug science

Reading, engaging with, and sharing our publications, papers and commentary gives evidence-based science and policy the audience it needs and deserves.

bottom of page